SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-23-274511
Filing Date
2023-11-09
Accepted
2023-11-09 16:13:30
Documents
1
Group Members
PANACEA INNOVATION LTDPANACEA VENTURE HEALTHCARE FUND II GP COMPANY, LTD.PANACEA VENTURE HEALTHCARE FUND II, L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d323955dsc13ga.htm SC 13G/A 85708
  Complete submission text file 0001193125-23-274511.txt   87361
Mailing Address 9620 MEDICAL CENTER DRIVE SUITE 300 ROCKVILLE MD 20850
Business Address
Huang James (Filed by) CIK: 0001573160 (see all company filings)

Type: SC 13G/A

Mailing Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025
Business Address 1701-1702, CHINA CENTRAL OFFICE TOWER 1 NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT BEIJING F4 100025 86 10 6561 8789
CASI Pharmaceuticals, Inc. (Subject) CIK: 0001962738 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94039 | Film No.: 231392567
SIC: 2834 Pharmaceutical Preparations